Related Experiment Video

Updated: Aug 14, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
03:24

A Catheter-Related Candida albicans Infection Model in Mouse

Published on: March 22, 2024

Clinical consequences of resistant Candida infections in intensive care

Philippe Montravers1, Khalil Jabbour

  • 1Department of Anaesthesia and Surgical Intensive Care Unit, Assistance Publique-Hopitaux de Paris, Hôpital Bichat Claude Bernard-Université Paris 7, France. philippe.montravers@bch.aphp.fr

International Journal of Antimicrobial Agents
|December 14, 2005
PubMed

Insights

Intensive Care Unit physicians face challenges in deciding antifungal therapy for Candida infections due to patient factors and potential resistance. While antifungal resistance risk seems low, further large-scale studies are needed.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Pharmacology

Background:

  • Candida infections pose significant risks in Intensive Care Units (ICUs).
  • Antifungal therapy selection is complex, influenced by patient-specific factors.
  • Emerging antifungal resistance is a growing concern in clinical practice.

Purpose of the Study:

  • To outline key considerations for Intensive Care Unit (ICU) physicians when prescribing antifungal therapy for Candida infections.
  • To discuss the implications of pharmacokinetic challenges and organ failure on treatment decisions.
  • To evaluate the risk of antifungal resistance development from prophylactic or pre-emptive strategies.

Main Methods:

  • Review of current clinical guidelines and literature on Candida infections and antifungal therapy.
  • Analysis of pharmacokinetic principles relevant to antifungal drug efficacy in critically ill patients.
  • Assessment of data regarding antifungal resistance patterns and selection pressures.

Main Results:

  • Physicians must weigh pharmacokinetic factors and organ dysfunction when choosing antifungals for Candida.
  • Extensive antifungal use may select for less susceptible Candida species, although the risk appears low.
  • Current evidence on resistance development from prophylactic/pre-emptive antifungal use is limited.

Conclusions:

  • Optimizing antifungal therapy in ICUs requires careful consideration of patient-specific pharmacokinetics and organ function.
  • While antifungal resistance is a potential risk, it appears low with current prophylactic/pre-emptive strategies.
  • Large-scale studies are necessary to definitively confirm the low risk of antifungal resistance and guide future therapeutic approaches.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...